Please login to the form below

Not currently logged in
Email:
Password:

Bristol Myers-Squibb

This page shows the latest Bristol Myers-Squibb news and features for those working in and with pharma, biotech and healthcare.

AZ’s immuno-oncology combo fails another lung cancer trial

AZ’s immuno-oncology combo fails another lung cancer trial

The news is particularly disappointing given that Bristol-Myers Squibb’s combination of PD-1 inhibitor Opdivo (nivolumab) and CTLA4 inhibitor Yervoy (ipilimumab) met its objectives in first-line NSCLC, besting

Latest news

More from news
Approximately 129 fully matching, plus 900 partially matching documents found.

Latest Intelligence

  • Accelerating innovation Accelerating innovation

    Leading this work is an agreement with Bristol-Myers Squibb to study a combination of Cabometyx and that firm’s blockbuster immuno-oncology drug Opdivo (nivolumab) and an agreement with Roche

  • Taking a lean and careful approach Taking a lean and careful approach

    Cerrone, who has a track record of seeding new enterprises, co-founded Synergy and also orchestrated the sale of Inhibitex to Bristol-Myers Squibb for $2.5bn.

  • Deal Watch March 2017 Deal Watch March 2017

    Sanofi, MedImmune, AstraZeneca, Astellas, Novartis and more feature in this month's pharma deals round-up

  • Deal Watch February 2017 Deal Watch February 2017

    From nutrition to body contouring . The largest deal of the month was Reckitt Benckiser's $17.9bn takeover of global paediatric nutrition company Mead Johnson, which was spun out of ... Myers Squibb in 2009.

  • Deal Watch January 2017 Deal Watch January 2017

    Actelion, Johnson & Johnson, Sanofi, Takeda and more feature in this month's pharma deals round-up

More from intelligence
Approximately 4 fully matching, plus 35 partially matching documents found.

Latest appointments

More from appointments
Approximately 10 fully matching, plus 97 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
90TEN Healthcare

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics